Antithrombotics in the Secondary Prevention of Events in Coronary Thrombosis-2 "ASPECT-2"


Phase N/A Results

Eligibility Criteria

Inclusion Criteria

Men and non-pregnant women with acute myocardial infarction or unstable angina within 8 weeks of onset.

Exclusion Criteria

Patients with contraindictions for the study drug, planned revascularization procedure, serious comorbidity, increased risk of bleeding, abnormal blood platelets, anaemia, history of stroke.